Headlines about Tivity Health (NASDAQ:TVTY) have been trending somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Tivity Health earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave news articles about the company an impact score of 43.0716888455452 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Here are some of the news articles that may have impacted Accern’s analysis:
- DEADLINE TOMORROW: The Klein Law Firm Reminds Shareholders of Commencement of a Class Action Filed on Behalf of Tivity Health, Inc. Shareholders and a Lead Plaintiff Deadline of January 19, 2018 (TVTY) (finance.yahoo.com)
- UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint on Behalf of Tivity Health, Inc. Shareholders and Lead Plaintiff Deadline of January 19, 2018 – TVTY (finance.yahoo.com)
- DEADLINE ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Over $100K in Losses of Class Action Against Tivity Health, Inc. (TVTY) & Lead Plaintiff Deadline: January 19, 2018 (finance.yahoo.com)
- TVTY Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tivity Health, Inc. (finance.yahoo.com)
- Stocks With Rising Relative Strength: Tivity Health (finance.yahoo.com)
Several equities analysts recently commented on TVTY shares. Oppenheimer boosted their target price on Tivity Health from $47.00 to $50.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 1st. Zacks Investment Research upgraded Tivity Health from a “hold” rating to a “buy” rating and set a $52.00 target price for the company in a research report on Tuesday, October 31st. ValuEngine cut Tivity Health from a “buy” rating to a “hold” rating in a research report on Monday, October 2nd. Jefferies Group restated a “buy” rating and set a $46.00 target price on shares of Tivity Health in a research report on Monday, September 25th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $45.00 target price on shares of Tivity Health in a research report on Monday, November 6th. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $46.25.
Tivity Health (NASDAQ:TVTY) opened at $38.55 on Friday. The stock has a market capitalization of $1,507.42, a PE ratio of 26.05, a PEG ratio of 2.02 and a beta of 0.18. Tivity Health has a fifty-two week low of $20.60 and a fifty-two week high of $48.50. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 0.02.
Tivity Health (NASDAQ:TVTY) last released its quarterly earnings results on Thursday, October 26th. The company reported $0.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.36 by $0.10. The company had revenue of $137.70 million during the quarter, compared to analyst estimates of $137.95 million. Tivity Health had a return on equity of 30.23% and a net margin of 11.45%. The company’s quarterly revenue was up 10.2% on a year-over-year basis. research analysts anticipate that Tivity Health will post 1.6 earnings per share for the current fiscal year.
In other Tivity Health news, CAO Glenn Hargreaves sold 5,805 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $45.15, for a total transaction of $262,095.75. Following the completion of the transaction, the chief accounting officer now owns 44,448 shares in the company, valued at $2,006,827.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Conan Laughlin sold 140,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 21st. The shares were sold at an average price of $34.90, for a total value of $4,886,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 875,892 shares of company stock valued at $31,815,642. 8.42% of the stock is currently owned by company insiders.
Tivity Health Company Profile
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.